Prostatic Neoplasms  >>  Torisel (temsirolimus)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Torisel (temsirolimus) / Pfizer
NCT00235794: An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients

Completed
N/A
50
US
temsirolimus
Wyeth is now a wholly owned subsidiary of Pfizer
Prostatic Neoplasms
 
09/07

Download Options